Skip to main navigation Skip to search Skip to main content

The "PIAS" Trial Prospective cross-sectional study of 68GA-PSMA PET/CT in addition to mpMRI in men undergoing active Surveillance for low- or intermediate-risk prostate cancer

  • Frydenberg, Mark (Primary Chief Investigator (PCI))

Project: Research

Project Details

StatusActive
Effective start/end date5/09/22 → 30/09/26

Keywords

  • Clinical Trial
  • V1.4 Dated 31 March 2022